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Abstract Patient education is highly recommended in rheu-
matoid arthritis (RA) to support patient management. The
challenge is to adhere to the recommendations for providing
health education to RA patients in Latin American and the
Caribbean (LAC) countries taking into account factors such
as patient health illiteracy, lack of rheumatologists, and lack of
resources including access to disease-modifying antirheumat-
ic drugs (DMARDs). As existing educational material in re-
gional languages is not readily available and inadequate, we
propose developing a web-based educational program that
would fulfill the requirements of most patients with RA across
LAC countries with an emphasis on the correct and safe use of
methotrexate.
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Rheumatoid arthritis (RA) is a chronic inflammatory disease
of the joints affecting 0.5–1 % of the adult population. RA
produces pain, fatigue, and work incapacity, is potentially dis-
abling, and shortens life expectancy. Much progress has been
made in RA treatment in the last decades with methotrexate
the cornerstone antirheumatic drug [1, 2]. Patient education is
highly recommended in RA to support patient management.
Guidelines for RA management say “Education for patients
with RA should be provided since first medical encounter”
[3]. Or recommend information to patients in the overarching
principle “Treatment of RA patients must be based on a shared
decision between the patient and the rheumatologist. Shared
decision-making includes the need to inform the patient of the
risks of RA and the benefits of reaching the targeted disease
activity states, as well as the pros and cons of respective ther-
apies. It also means two-way communication and joint or
shared decision-making on the therapeutic target and manage-
ment plan as well as support for the patient to develop person-
al preferences” [4]. Guidelines are endorsed by the Pan Amer-
ican League of Associations of Rheumatology (PANLAR)
and all national rheumatology-affiliated societies and “Grupo
Latino Americano de estudio De Artritis Reumatoide”
(GLADAR) [5, 6]. Therefore, structured patient education
should be available to all people with RA at initial diagnosis
and on an ongoing basis, based on a formal, regular assess-
ment of needs as the National Institute for Health and Care
Excellence of the UK advocates (https://www.nice.org.uk/
guidance/qs33). Implementing these recommendations and
providing patient education in clinical practice in Latin
America and the Caribbean is a challenge.
Some aspects that should be discussed in particular in the
audio-visual material are listed here:
1. Adverse effects of medications in contrast to benefits.
2. Discuss diet and give dietary advice, taking into account
other factors (e.g., obesity, hypertension, renal impair-
ment); offer referral to a nutrition or dietician; also take
into account hand/wrist incapacities to prepare food.
3. Encourage regular physical activity, taking into ac-
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4. Give advice and support on smoking cessation where
appropriate.
5. Mobility, driving and using national transport system.
6. Getting help.
7. Finding positive activities.
8. Knitting? Embroidery? What there is the need for?
9. DAS28? What is it for?
10. How to ease morning stiffness.





15. Avoiding people with TB.
16. When to seek help. Who is my contact if a drug adverse
effect takes place?
17. What are biologics drugs?
18. What if I miss a dose of my medications?
19. What it means to be under immunosuppressive
medication.
20. What medications can be combined?
21. Use of non steroidal anti-inflammatory drugs.
22. Marihuana for pain.
23. Sexuality and family planning.
24. Drinking wine and spirits.
25. Rights of patients with RA according to their country
and health system.
26. Illness beliefs and integration of alternative and comple-
mentary medicine in RA therapy.
27. Work-related and lifestyle-related advice.
Inequities in health care are a reality in Latin America and
the Caribbean (LAC). There are many problems to face re-
garding the actual standard of care of patients with RA in
LAC, including few rheumatologists and very few allied
health professionals working in RA [6]. Moreover, rheuma-
tology is not part of the undergraduate curricula in many med-
ical schools (results of a 2014 PANLAR survey, unpublished
communication). For the majority of clinical rheumatologists,
the workload is heavy, time assigned per visit is short, and
waiting lists are long [5, 6]. Methotrexate in oral form is the
disease-modifying antirheumatic drug (DMARD) available in
most centers due to both low costs and its effectiveness in at
least 50 to 75% of patients. However, this may also depend on
whether treatment was initiated within “the window of oppor-
tunity” whereas other DMARDs or biologics are difficult to
access due to their expensive costs [7]. Understandably, in
these working conditions, to fully apply treat to target strate-
gies [4] is not possible. Health education for patients with RA
and caregivers is not a priority, although rheumatologists
would agree that it is necessary.
Therefore, it is relevant to develop a LAC health-
educational program to help doctors in busy clinical practices
to provide education to RA patients, taking into account dif-
ficulties attributable to health system organizations and work-
ing conditions, poverty, and other socioeconomic factors. Par-
ticularly, when a recent study in early RA patients from the
GLADAR cohort showed that low/middle low socioeconomic
status (SES) is associated with more active disease and worse
functional capacity [8]. It is possible that a health education
program based on this reality could positively impact the out-
come of RA or health-related quality of life. Thus, patients
would be able to make optimal and safe use of methotrexate
[9] and other medications and therapies and adopt healthier
conduct. In our opinion, patients from low/middle low SES,
illiterate or semi-illiterate patients, patients living in rural or
suburban conditions, or manual laborers who are at risk of
losing their jobs are in most need of health education if they
suffer from RA and possibly would benefit more. In LAC, the
most social and economic support for RA patients is provided
by the family, as pensions for disability, sick leave, or antici-
pated retirement are low and under the requirements for a
severe disease, and most patients find little or no social sup-
port from the state or their health system coverage. Every
effort to provide health educational material to all LAC pa-
tients with RA and their families must be done. Especially
when considering that there are few rheumatologists and dif-
ficulties in accessing medical visits and free medications
across LAC countries.
Education measures for RA
Health education is a planned learning experience that influ-
ences the knowledge of the patient about his/her illness aiming
to modify health habits/conduct in order to be able to collab-
orate in their therapy [10–12]. It utilizes a combination of
learning methods, counseling, and techniques to modify con-
duct. It is an interactive process to help the individual to par-
ticipate in their self-care and to make optimal use of all health
resources. The relevance of patient education safety programs
has been put forward by the Joint Commission on Accredita-
tion of Healthcare Organizations (JCAHO) (http://www.
jointcommission.org/speakup.aspx). As mentioned by Fox
[13], the JCAHO requires patient education standards as a
condition of accreditation, including requirements related to
understandability and readability, ease of access to materials,
and consideration of language differences and patient abilities.
However, it is not clear what type of educational interventions
is most effective in improving health status for patients with
chronic diseases [14]. Education strategies can vary from the
provision of information only to the use of cognitive-
behavioral strategies. Formats include verbal, written, audio-
visual, and interactive computer-based educational programs
[13]. The objectives of patient education in RA are to improve
patient outcomes as well as to obtain the best of the affordable
S46 Clin Rheumatol (2015) 34 (Suppl 1):S45–S49
therapies available. From 31 education trials in RA included
in a meta-analysis, significant benefits of patient education at
first follow-up are modest (5–12 %). The most important ben-
efit was observed in functional disability; additionally, behav-
ioral programs versus controls had better results than informa-
tion only or counseling [15]. Verbal information given by
physicians on how to take prescriptions or drug side effects
is not understood, not recalled, or not remembered incorrectly
affecting patient adherence [16] even though it is the most
common format used in hospitals/clinics. Therefore, printed
material and multimedia are likely better options.
Patient education is made up of knowledge, abilities and
conducts, and psychological support. In RA, focus should be
on obtaining and maintaining remission, prevention of re-
lapses, and avoiding deformities and damage. If there is dis-
ability due to RA, how to adapt to this condition should be
covered. Patients can learn the significance of adherence to
therapies, attending regular controls, recognize possible com-
plications on time, manage depression and anxiety symptoms,
control co-morbidities, and avoid health risk conducts. Pa-
tients should be encouraged to maintain adequate body mass
index and exercise, to follow vaccine programs, and to avoid
infections. Patients should also adopt joint protection strate-
gies [17]. Lack of awareness of health conducts directly af-
fects patient’s response to treatment and outcomes or
obtaining an acceptable health-related quality of life (http://
www.uptodate.com/contents/arthritis-beyond-the-basics).
Providing effective health education for RA patients has many
difficulties. A recent study has shown that RA educational
needs varies in relation to gender, personal characteristics,
disease activity, and disease duration indicating that
education be targeted more effectively. Correlations between
educational needs and disease activity and function could
enable identification of ‘intervention points’, which can be
ideal opportunities for effective patient education [18].
A challenge often faced by LAC physicians when they
approach patients with RA under their care is that they have
health illiteracy or do not read, which both jeopardize patient
c omp l i a n c e [ 19 , 20 ] ( h t t p : / /www.h e a l t h . g ov /
communication/). In LAC countries, patients often follow
complementary and alternative medicine [21, 22] or magical
cures that may greatly modify the therapeutic plan the
rheumatologists consider more appropriate. An educational
program should deal with doubts and help people with RA
to take informed decisions considering risks and benefits [19].
When patients ask for information about RA, answers should
be given in simple terms. However, this should not preclude
offering the correct information particularly on methotrexate
safe and correct use [19]. A respectful approximation of
patient’s beliefs identifying the preoccupations, expectations,
emotions, and interests of patients would allow the
“coincidence of agendas of both patient and doctor” [23, 24]
that would permit choosing the individualized health
educational material. Therefore, we propose including
courses on patient education as well physician-patient com-
munication skills at a professional level of competence at
PANLAR meetings as part of the continuing medical educa-
tion in rheumatology.
There are suitable programs that could be applied to RA
patients in groups such as the Chronic Disease Self-
Management Program of the Stanford University [11] given
in six workshops to 10–12 participants. People with RA that
attended this workshop did not show any benefit in biomedi-
cal or lifestyle outcomes at 3 years, although there were
sustained improvements in some illness beliefs. However, in
a short period, the benefit was evident [12, 15, 25]. In 2006,
training of people from ten Latin American countries in Pan-
ama was started but the effort did not continue and workshops
were not repeated.
A review of web pages in Spanish shows sites providing
information for patients and lay people on RA. The Medical
Library of National Institute of Health from the US (http://
www.nlm.nih.gov/medlineplus) and the American College
of Rheumatology provide information for Spanish-speaking
people with RA living in the USA explaining drug mecha-
nisms of actions and adverse effects using commercial names
in the USA. The National Institute of Arthritis and Musculo-
skeletal and Skin diseases web page offers little information
(http://www.niams.nih.gov) whereas Wikipedia (http://es.
wikipedia.org) offers an up-to-date text appropriate for those
with biomedical knowledge. The Sociedad Española de
Reumatología (www.ser.es) has developed a brochure with
detailed explanations on pathogenesis, clinical features, and
therapy; however, it is difficult for LAC patients to identify the
drug names. Pharmaceutical companies publish educational
material for patients that lack individualization and need
revisions to assure the absence of bias. Common to all pages
is the use of a minimum visual support, lack of audio, and no
interactive web page in Spanish or Portuguese. In summary,
there is a need for web-based material for patients adapted to
the specific needs of LAC patients with RA and the diverse
reality in LAC countries.
Educational program for LAC RA patients:
a proposal for a solution
The challenge is to adhere to the recommendations for pro-
viding health education to RA patients in LAC taking into
account the previously explained difficulties and lack of re-
sources. As existent material is not easily available and inad-
equate, we propose developing an educational program that
would fulfill the requirements of most patients with RA across
LAC countries. The proposal will need support from PANL
AR, resources, and funding, but costs and details are not
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within the scope of this manuscript. We will briefly review the
program we conjecture our patients would benefit from.
Our aim is that the RA patient educational material devel-
oped by PANLAR be offered to doctors and patients in a
variety of formats the patient can choose from. The design
will require short interventions with minimal contents ex-
plained clearly that could be given in each visit by the attend-
ing physician or under his/her direction and if possible, by
health personnel and trained RA patients. This should be re-
inforced afterwards or at home.
The need to be scientifically valid is very importantly, and
thus, every statement of the content will be based on evidence-
based medicine or medical expert opinions when there is no
evidence. As evidence changes, the program will be updated
and reviewed annually.
We propose to develop a written and audio-visual material
on a website based on plain local languages (in Spanish, in-
cluding indigenous languages and Portuguese) that could be
printed on one page in a letter case easily read (size 12), with
headings and titles identifying the contents in a sequence that
could be followed as needed. This material will be published
online on the PANLAR educational website. As many pa-
tients, especially the elderly, do not have media access, they
could be given printed material at the clinic visit, according to
their needs. Videos should be posted on Youtube with fre-
quently asked questions from a patient with an appointed doc-
tor of about 5 min each. Rheumatologists, patients, linguist
specialists, nurses, occupational therapists, physiotherapists,
physiatrists, psychiatrists, psychologists, and education and
multimedia experts will participate in the development of the
material.
Additionally, patients will be directed to official ACR
websites in Spanish and from the “Sociedad Española de
Reumatología” and to EDUCAR, a website of PANLAR ded-
icated to continuing medical education in RA. Patient ques-
tions should be directed to the program by doctors or patients
themselves to receive an expert response. A list of health pro-
viders containing rheumatology centers fulfilling local quality
standards and qualified staff will be accessible from the web
page of the educational site. A diffusion campaign to doctors
and patient associations through email from PANLAR will be
done. We are aware that the site should be found easily and be
on the first two pages of Google.
Content of the education program
Knowledge. Basic articular anatomy notions, inflammation
notions, DMARDs mechanisms of action, and adverse effects
with emphasis on the correct and safe use of methotrexate.
What rheumatologists assess in a clinic visit such as articular
indices and registries. Qualified/accredited health providers
locally and at a national level. A list of available resources
for RA and patient associations in LAC will also be included.
Abilities and conducts. Regular low-impact exercise com-
bined with rest periods. Adaptation measures at work and in
daily life. Promote adherence to therapy. Following vaccina-
tion schedule according to local regulations. Eating a healthy
diet. How to proceed if an adverse effect appears.
Psychological support including self-help and treatment
for anxiety and depression when needed. Communication
strategies, support from family, and available social agencies.
The table lists some aspects that should be discussed in par-
ticular in the audio-visual material.
Evaluation of the education program
A survey will be sent out at 3 and 12 months to patient asso-
ciations about readability, acceptance, and recall of the mate-
rial and to rheumatologists about problems, questions, and
suggestions. Also, a web page visit counts. This evaluation
and revision will proceed annually.
In conclusion, there is an unmet need for patient health
education in rheumatology in LAC, including patients with
RA and their families. To reach more people with RA, infor-
mation should be in various formats; written and audio-visual
based on the web with an emphasis on the correct and safe use
of methotrexate.
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